SCHEMBL4237159

SCHEMBL4237159

O=C(O)c1ccc(CCC2=CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.47
S1PR5 Q9H228 1/20 0.47
HDAC1 Q13547 2/20 0.46
HDAC4 P56524 2/20 0.46
KCNH2 Q12809 1/20 0.46
PTGER4 P35408 2/20 0.45
PTGER2 P43116 2/20 0.45
HDAC6 Q9UBN7 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARA Q07869 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
NAMPT P43490 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KDM1A O60341 1/20 0.41
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8984029 0.88 SIGMAR1 (0.50) S1PR1S1PR5DRD2DRD4DRD3
SCHEMBL4238906 0.81 PTGER4 (0.41) PTGER4PTGER2MEN1KMT2APPARA
SCHEMBL4030523 0.80 HDAC4 (0.61) S1PR1HDAC4MEN1KMT2ANAMPT
SCHEMBL4233494 0.80 RARB (0.48) KCNH2PTGER4PTGER2MEN1KMT2A
SCHEMBL1588025 0.79 SIGMAR1 (0.47) HDAC4NAMPTDRD2DRD4DRD3
SCHEMBL7868181 0.79 CCR3 (0.51) DRD2DRD4DRD3
SCHEMBL3041337 0.78 HDAC4 (0.60) S1PR1S1PR5HDAC1HDAC4KCNH2
SCHEMBL12574593 0.78 ALDH1A1 (0.47) HDAC4KMT2ANAMPTALDH1A1DRD2
SCHEMBL27519383 0.77 HDAC4 (0.71) HDAC1HDAC4KCNH2MEN1KMT2A
SCHEMBL5230749 0.77 SIGMAR1 (0.44) HDAC4NAMPTDRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R S1PR1 354/4885S1PR5 276/4885HDAC1 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.